AI assistant
Sending…
Vir Biotechnology, Inc. — Director's Dealing 2021
Feb 12, 2021
32538_dirs_2021-02-12_328eb677-f98e-4728-af09-4c942d40ce66.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2020-12-31
Reporting Person: Parrish Jay (Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-03 | Common Stock | G | 106481 | $0.00 | Disposed | 115741 | Direct |
| 2020-04-03 | Common Stock | G | 106481 | $0.00 | Disposed | 9260 | Direct |
Footnotes
F1: Gift by the Reporting Person for estate planning purposes to an irrevocable trust which is managed by an independent trustee. The Reporting Person holds no voting or dispositive power over the securities held by the trust.
F2: Gift by the Reporting Person for estate planning purposes to an irrevocable trust which is managed by an independent trustee. The Reporting Person holds no voting or dispositive power over the securities held by the trust.
More from Vir Biotechnology, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 10
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 4
Director's Dealing
2026
Mar 3
Capital/Financing Update
2026
Mar 2
Capital/Financing Update
2026
Feb 26